Vimarsana
Biggest News Aggregation in the World

Cytyc Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cytyc Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cytyc Corp Today - Breaking & Trending Today

Biomed 2024 Showcases Israel's Resilient Entrepreneurial Spirit - Vimarsana News

Biomed 2024 Showcases Israel's Resilient Entrepreneurial Spirit

The 22nd Biomed Israel Conference brings together Israeli Biotech startups, senior pharma and healthcare executives, and global investors.

Source: forbes.com
CellMax Life Announces Expansion of Company Board With Leading Industry Experts - Vimarsana News

CellMax Life Announces Expansion of Company Board With Leading Industry Experts

SUNNYVALE, Calif. April 6, 2023 (PRWEB) April 06, 2023 -- CellMax Life, a molecular diagnostics company with a proprietary colorectal cancer screening blood

Source: prweb.com
Hologic, Inc. v. Minerva Surgical, Inc. (Fed. Cir. 2022) | McDonnell Boehnen Hulbert & Berghoff LLP - Vimarsana News

Hologic, Inc. v. Minerva Surgical, Inc. (Fed. Cir. 2022) | McDonnell Boehnen Hulbert & Berghoff LLP

Last year, the Supreme Court declined an invitation to abrogate the doctrine of assignor estoppel by an assignor sued for patent infringement in Minerva Surgical v. Hologic. ...

Supreme Court Grants Certiorari to Resolve Long-Running Debate on Assignor Estoppel | Snell & Wilmer - Vimarsana News

Supreme Court Grants Certiorari to Resolve Long-Running Debate on Assignor Estoppel | Snell & Wilmer

Last Friday, the U.S. Supreme Court granted certiorari in Minerva Surgical v. Hologic, thereby agreeing to resolve a long-running debate on patent law’s doctrine of assignor estoppel. Minerva Surgical has asked the Court to abolish the doctrine, which bars inventors who sell their patent rights from challenging the patent’s validity in district court. The inventor in this case, Csaba Truckai, co-founded a company called NovaCept and developed two patents for endometrial ablation, a surgical process used to treat menstrual bleeding. NovaCept sold its patents to Cytyc Corp., which was acqu...